Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA PFIZER SHUKRA PHARMA/
PFIZER
 
P/E (TTM) x 19.3 38.2 50.5% View Chart
P/BV x 14.1 6.0 236.3% View Chart
Dividend Yield % 0.2 1.7 9.2%  

Financials

 SHUKRA PHARMA   PFIZER
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
PFIZER
Mar-23
SHUKRA PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs894,662 1.9%   
Low Rs113,407 0.3%   
Sales per share (Unadj.) Rs53.7530.0 10.1%  
Earnings per share (Unadj.) Rs4.0136.4 2.9%  
Cash flow per share (Unadj.) Rs5.7159.4 3.6%  
Dividends per share (Unadj.) Rs0.5070.00 0.7%  
Avg Dividend yield %1.01.7 57.7%  
Book value per share (Unadj.) Rs23.1701.0 3.3%  
Shares outstanding (eoy) m10.9645.75 24.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.97.6 12.2%   
Avg P/E ratio x12.429.6 42.0%  
P/CF ratio (eoy) x8.825.3 34.6%  
Price / Book Value ratio x2.25.8 37.6%  
Dividend payout %12.451.3 24.2%   
Avg Mkt Cap Rs m547184,576 0.3%   
No. of employees `000NANA-   
Total wages/salary Rs m443,317 1.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m58824,248 2.4%  
Other income Rs m121,011 1.2%   
Total revenues Rs m60025,258 2.4%   
Gross profit Rs m548,420 0.6%  
Depreciation Rs m181,055 1.7%   
Interest Rs m3135 2.1%   
Profit before tax Rs m448,240 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m02,001 0.0%   
Profit after tax Rs m446,239 0.7%  
Gross profit margin %9.134.7 26.3%  
Effective tax rate %0.824.3 3.3%   
Net profit margin %7.525.7 29.1%  
BALANCE SHEET DATA
Current assets Rs m53124,933 2.1%   
Current liabilities Rs m4256,574 6.5%   
Net working cap to sales %18.075.7 23.7%  
Current ratio x1.23.8 32.9%  
Inventory Days Days093 0.0%  
Debtors Days Days1,8732 81,994.5%  
Net fixed assets Rs m21913,780 1.6%   
Share capital Rs m39458 8.6%   
"Free" reserves Rs m21431,616 0.7%   
Net worth Rs m25332,073 0.8%   
Long term debt Rs m380-   
Total assets Rs m75039,031 1.9%  
Interest coverage x16.862.1 27.1%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.80.6 126.3%   
Return on assets %6.316.3 38.3%  
Return on equity %17.419.5 89.5%  
Return on capital %16.226.1 62.2%  
Exports to sales %02.8 0.0%   
Imports to sales %00 0.0%   
Exports (fob) Rs mNA688 0.0%   
Imports (cif) Rs mNA8 0.0%   
Fx inflow Rs m0688 0.0%   
Fx outflow Rs m08 0.0%   
Net fx Rs m0679 0.0%   
CASH FLOW
From Operations Rs m323,557 0.9%  
From Investments Rs m-44-361 12.3%  
From Financial Activity Rs m49-3,458 -1.4%  
Net Cashflow Rs m37-262 -14.1%  

Share Holding

Indian Promoters % 51.0 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.1 18.2 0.6%  
FIIs % 0.0 3.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 36.1 135.9%  
Shareholders   10,963 112,456 9.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs Pfizer Share Price Performance

Period RELISH PHARMA Pfizer S&P BSE HEALTHCARE
1-Day -2.00% -4.80% 1.18%
1-Month 18.32% -8.24% -0.75%
1-Year 528.10% 21.78% 61.82%
3-Year CAGR 229.50% -2.07% 18.16%
5-Year CAGR 114.18% 4.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.